11 November 2025NewsEuropeMarisa Woutersen

7 in-house counsel tips for partnering with AI vendors

Partnering with AI vendors can open doors for startups and small companies but it also brings serious risks. Experts at AI & IP Europe share key lessons on contracts, data ownership, ring-fencing, monitoring, and exit planning, as Marisa Woutersen reports.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Why AI is changing the patent rules faster than anyone can keep up

24 October 2025 A panel of experts at LSPN shared how AI is forcing companies to rethink everything from obviousness arguments to the choice between patents and trade secrets, and why the claims filed today may be invalid tomorrow.

Big Pharma

Moderna TM counsel: Commoditising work using AI is a ‘moral obligation’

16 October 2025 After saving hundreds of thousands of dollars ‘with my laptop and ChatGPT’, the biotech’s trademarks leader says lawyers need to discover how the tech can reduce external spend.

Big Pharma

Chemical reaction: Why AI drug discovery demands a new IP plan

6 August 2025 With AI accelerating drug development, pharma companies must rethink how they protect models, data, and innovation, say Camille Terfve and Sean Jauss of Mewburn Ellis.

More features

UPC draws hard line on urgency in first SPC dispute

Patent and SPC litigator makes the move from Carpmaels

EU Pharma Package hits the final stretch—but can negotiators agree?

UPC appeals court hands Amgen a win in cholesterol dispute

Squires affirms USPTO’s stance on AI with revised guidance

UPC judges call for greater female advocacy at court

The clinical trial dilemma: Navigating European practice

Novartis counsel on managing patents at a $50bn company

7 in-house counsel tips for partnering with AI vendors

More on this story

Editor's picks

Editor's picks

More features